The number of gauging cross-sections where a statistically significant decreasing trend was identified. by Krzysztof Kochanek (835532)

Mean decrease Gini score by Tweet and user characteristics. by Gray Babbs (16648894)

Shift of measured dose distribution. by Seongmoon Jung (9310778)

Subjects:

Changes of PVS ratios and volumes for different treatment periods and different dose levels (HD: high dose, SD: standard dose, and RD: reduced dose). by Ruitian Song (11045127)

Decrease of the mean number of natural teeth and POPs with age. by Sul-Hee Kim (11873853)

Additional doses of pyridoxine, vincristine sulfate and ionomycin tested on female and male rat DRGs induced axonal dieback without significant neurotoxicity. by Fei San Lee (17282886)

“…<p>At higher doses, axon length ratio significantly decreased with (<b>A</b>) 1 mM Pyr, (<b>C</b>) 200 nM Vcr and 500 nM Vcr compared to matched solvent controls in female rat DRGs as expected. …”

Image_1_Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy.pdf by Jessica Prunaretty (13263912)

“…Last, the relationship between MHD and the heart volume or LAD coronary artery volume receiving at least 30Gy, 40Gy and 45Gy in function of each additional 1Gy to the MHD was assessed (study C).</p>Results<p>A significant decrease of heart and LAD coronary artery exposure to high dose was observed with the IMRT compared with the 3D conformal radiotherapy plans that both ensured adequate target coverage (study A). …”

Determinants of calculated systematic and random errors. by Rashid Mussa Mruma (17980110)

Subjects:

Gross error determination according to employed off-line correction protocol. by Rashid Mussa Mruma (17980110)

Subjects:

Calculated random and systematic errors in the three orthogonal directions (longitudinal, lateral, and vertical). by Rashid Mussa Mruma (17980110)

Subjects:

S1 Raw data - by Rashid Mussa Mruma (17980110)

Subjects:

Socio-demographic characteristics and clinical information (N = 45). by Rashid Mussa Mruma (17980110)

Subjects:

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

Subjects:

The mean relative risk reduction (RRR) of health outcomes for the alternative starting time modeled with (A) IBM and (B) MPM. by Louis Yat Hin Chan (14493190)

Subjects:

The effects of different doses of CDCA in mice. by Shuaijun Peng (21177041)

Subjects:

When bacteria are primed with melittin and challenge with pexiganan and the opposite, there are not significant differences between primed and non-primed populations. by Alexandro Rodríguez-Rojas (326213)

Quantitative evaluation of the different dose levels. by Rafael C. Schick (20479922)

Subjects:

Significant clusters for zero-dose children aged 12-23 months in Ethiopia, 2023. by Berhanu Fikadie Endehabtu (9218109)

Subjects:

Subgroup analysis. by Bruno Martins Tomazini (6509528)

Subjects:

Study outcomes. by Bruno Martins Tomazini (6509528)

Subjects: